Zybin D.I., Seregin A.S., Askretkov A.D., Orlova N.V., Seregin Yu.A., Prostyakova A.I., Kapustin D.V. Development and validation of a method for the determination of the specific activity of recombinant monoclonal antibody eculizumab. Fine Chemical Technologies. 2020;15(2):77-85. https://doi.org/10.32362/2410-6593-2020-15-2-77-85
Email this article (Login required)
Email the author (Login required) 
86, R-108, Vernadskogo pr., Moscow, 119571, Russian Federation
MIREA - Russian Technological University (RTU MIREA),
M.V. Lomonosov Institute of Fine Chemical Technologies
Managing Editor: Galina D. Seredina, Phone: +7 499 600-80-80 (#31288), E-mail: seredina@mirea.ru
Editor: Sofya M. Mazina, E-mail: mazina@mirea.ru
Processing of personal data
